enVVeno Medical Says It Received FDA IDE Approval For TAVVE Pivotal Study Of enVVe Replacement Venous Valve, Enrollment Of Approximately 230 Patients Expected To Begin In H2 2026

Loading news article.

enVVeno Medical Says It Received FDA IDE Approval For TAVVE Pivotal Study Of enVVe Replacement Venous Valve, Enrollment Of Approximately 230 Patients Expected To Begin In H2 2026 | WAPE

enVVeno Medical Says It Received FDA IDE Approval For TAVVE Pivotal Study Of enVVe Replacement Venous Valve, Enrollment Of Approximately 230 Patients Expected To Begin In H2 2026

Article summary

Related companies

Comments —